These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 14071275)

  • 41. [ON THE EFFECT OF DEXTRAN SULFATE ON SABIN ORAL POLIOMYELITIS VACCINAL STRAINS].
    VOSS H
    Z Naturforsch B; 1964 Mar; 19():226-9. PubMed ID: 14175997
    [No Abstract]   [Full Text] [Related]  

  • 42. Measurement of the protective effect of attenuated poliovirus vaccine.
    KNOWELDEN J; HALE JH; GARDNER PS; LEE LH
    Br Med J; 1961 May; 1(5237):1418-20. PubMed ID: 13757211
    [No Abstract]   [Full Text] [Related]  

  • 43. [DYNAMICS OF SEROLOGICAL SHIFTS IN CHILDREN VACCINATED WITH LIVE POLIOMYELITIS VACCINE FROM SABIN STRAINS].
    TARANOVA GP
    Vopr Virusol; 1963; 29():409-15. PubMed ID: 14071276
    [No Abstract]   [Full Text] [Related]  

  • 44. [COMPARATIVE ATTEMPTS TO DEMONSTRATE ANTIBODIES AGAINST POLIOMYELITIS VIRUS WITH THE NEUTRALIZATION TEST AND THE IMMUNOFLUORESCENCE METHOD].
    BOSELLA F
    Boll Ist Sieroter Milan; 1964; 43():249-52. PubMed ID: 14199041
    [No Abstract]   [Full Text] [Related]  

  • 45. CONTRIBUTION TO THE KNOWLEDGE OF ENTEROPATHIES OF VIRAL ORIGIN. STUDIES AND REMARKS ON THREE OUTBREAKS BY ENTEROVIRUSES (POLIOVIRUS AND ECHO VIRUS).
    GIOVANARDI A; BERGAMINI F
    Arch Gesamte Virusforsch; 1963 Oct; 14():15-26. PubMed ID: 14099581
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunization with live attenuated poliovirus vaccine.
    KRUGMAN S; WARREN J; EIGER MS; BERMAN PH; MICHAELS RM; SABIN AB
    Am J Dis Child; 1961 Jan; 101():23-9. PubMed ID: 13754588
    [No Abstract]   [Full Text] [Related]  

  • 47. Properties and behavior of orally administered attenuated poliovirus vaccine.
    SABIN AB
    J Am Med Assoc; 1957 Jul; 164(11):1216-23. PubMed ID: 13438685
    [No Abstract]   [Full Text] [Related]  

  • 48. EVALUATION OF COMMUNITY VACCINATION AGAINST POLIOMYELITIS IN HOUSTON, TEXAS, 1962.
    MELNICK JL; PARKS WP
    Am J Hyg; 1964 Sep; 80():157-74. PubMed ID: 14215827
    [No Abstract]   [Full Text] [Related]  

  • 49. POLIOVIRUS SHEDDING AND SEROCONVERSION. STUDIES OF 816 COSTA RICAN CHILDREN FED TRIVALENT VACCINE.
    ROCA-GARCIA M; MARKHAM FS; COX HR; VARGAS-MENDEZ O; GUEVARA EC; MONTOYA JA
    JAMA; 1964 May; 188():639-46. PubMed ID: 14121285
    [No Abstract]   [Full Text] [Related]  

  • 50. Status of field trials with an orally administered, live attenuated poliovirus vaccine.
    SABIN AB
    J Am Med Assoc; 1959 Oct; 171():863-8. PubMed ID: 14440556
    [No Abstract]   [Full Text] [Related]  

  • 51. THE RESPONSE AND THE LACK OF SPREAD IN SWEDISH SCHOOL CHILDREN GIVEN AN ATTENUATED POLIOVIRUS VACCINE PREPARED IN A HUMAN DIPLOID CELL STRAIN.
    PAGANO JS; BOETTIGER M; BONNEVIER JO; GARD S
    Am J Hyg; 1964 Jan; 79():74-85. PubMed ID: 14114357
    [No Abstract]   [Full Text] [Related]  

  • 52. Proposed method and evaluation of the monkey neurovirulence test for attenuated poliovirus vaccine.
    JUNGHERR EL; CABASSO VJ; MOYER AW; COX HR
    J Infect Dis; 1961; 108():247-61. PubMed ID: 13791071
    [No Abstract]   [Full Text] [Related]  

  • 53. 1963 EPIDEMIC OF POLIOMYELITIS IN BARBADOS, WEST INDIES.
    LEEDOM JM; GRAHAM AC; BYER MA
    Public Health Rep (1896); 1965 May; 80(5):423-31. PubMed ID: 14290592
    [No Abstract]   [Full Text] [Related]  

  • 54. Interference patterns encountered when using attenuated poliovirus vaccines.
    HALE JH; LEE LH; GARDNER PS
    Br Med J; 1961 Sep; 2(5254):728-32. PubMed ID: 13710702
    [No Abstract]   [Full Text] [Related]  

  • 55. [STUDIES ON THE COMPLEMENT-BINDING REACTION OF POLIOMELITIS. V. USE OF 11 SEROLOGICALLY DEFINED TYPE I AND TYPE II ANTIGENS IN EXAMINATION OF PATIENT SERA].
    SCHMIDT WA; HOEPKEN W; WOHLRAB R
    Arch Gesamte Virusforsch; 1964 Mar; 14():521-36. PubMed ID: 14184627
    [No Abstract]   [Full Text] [Related]  

  • 56. [Poliomyelitis in New Caledonia. Virological and serological data. Pre-immune status and post-vaccinal seroconversion. Prophylactic strategy].
    Panon G; Louis JP; Le Gonidec G
    Bull Soc Pathol Exot Filiales; 1985; 78(3):321-33. PubMed ID: 2992831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [STUDIES ON THE DETECTION OF NEUTRALIZING AND COMPLEMENT BINDING ANTIBODIES FOLLOWING ORAL POLIOMYELITIS VACCINATION].
    SCHMIDT J; NAUMANN G
    Klin Wochenschr; 1965 May; 43():562-9. PubMed ID: 14304399
    [No Abstract]   [Full Text] [Related]  

  • 58. Complementfixing antigens of living and inactivated poliovirus. I. Complement-fixing antibody response of laboratory animals to poliovirus.
    HARE JD; WARREN J
    Am J Hyg; 1958 May; 67(3):350-66. PubMed ID: 13533408
    [No Abstract]   [Full Text] [Related]  

  • 59. [BEHAVIOR OF POLIO ANTIGENS IN THE ECTEOLA CELLULOSE ION-EXCHANGE ADSORBENT].
    SCHMIDT WA
    Arch Gesamte Virusforsch; 1963 May; 13():368-74. PubMed ID: 14046082
    [No Abstract]   [Full Text] [Related]  

  • 60. [Levels of specific antibodies against poliomyelitis virus and degree of immune protection in Umbria population].
    Stagni G; Merletti L; De Rosa F
    Boll Ist Sieroter Milan; 1979 Jul; 58(3):210-5. PubMed ID: 229884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.